Kite Pharma’s ASCO ads aim to prep docs on CAR-T ahead of FDA approval – FiercePharma
FiercePharma |
Kite Pharma's ASCO ads aim to prep docs on CAR–T ahead of FDA approval
FiercePharma Kite Pharma is hoping to bring the first CAR–T drug to the U.S. this year with its candidate KTE-C19. Kite began its rolling submission with the FDA in early December for an indication in relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma … |
